Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 07/07/20151 min de leitura
CHEMBIOMED, LTD.; Revocation of U.S. License No. 0916
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the revocation of the biologics license (U.S. License No. 0916) issued to CHEMBIOMED, LTD. (CHEMBIOMED) for the manufacture of Anti-A (Murine Monoclonal), Anti-B (Murine Monoclonal), Anti-Le\a\ (Murine Monoclonal) and Anti-Le\b\ (Murine Monoclonal). CHEMBIOMED did not respond to a notice of opportunity for a hearing on a proposal to revoke its license.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →